Elekta AB (publ) Market Cap ($2.36 Billion)
Market Cap & Net Worth: Elekta AB (publ) (EKTA-B)
Elekta AB (publ) market cap. Elekta AB (publ) (ST:EKTA-B) has a market capitalization of $2.36 Billion (Skr21.92 Billion) as of November 1, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #5407 globally and #77 in its home market, demonstrating a 6.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elekta AB (publ)'s stock price Skr59.70 by its total outstanding shares 367102351 (367.10 Million). Also see cash flow conversion of Elekta AB (publ) for how efficiently the company converts equity into cash flow.
Elekta AB (publ) Market Cap History (2015–2026)
Elekta AB (publ) market cap history from 2015 to 2026. Data shows growth from $2.38 Billion to $2.36 Billion (0.93% CAGR). Check Elekta AB (publ) (EKTA-B) stock price for real-time trading data and today's change.
Elekta AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elekta AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore EKTA-B shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.12x
Elekta AB (publ)'s market cap is 0.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
9.46x
Elekta AB (publ)'s market cap is 9.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.67 Billion | $11.22 Billion | $137.00 Million | 0.24x | 19.50x |
| 2017 | $2.27 Billion | $10.70 Billion | $125.00 Million | 0.21x | 18.18x |
| 2018 | $3.59 Billion | $11.33 Billion | $1.10 Billion | 0.32x | 3.27x |
| 2019 | $4.26 Billion | $13.55 Billion | $1.20 Billion | 0.31x | 3.56x |
| 2020 | $3.88 Billion | $14.60 Billion | $1.08 Billion | 0.27x | 3.58x |
| 2021 | $4.10 Billion | $13.76 Billion | $1.25 Billion | 0.30x | 3.27x |
| 2022 | $2.32 Billion | $14.55 Billion | $1.15 Billion | 0.16x | 2.01x |
| 2023 | $3.14 Billion | $16.87 Billion | $943.00 Million | 0.19x | 3.33x |
| 2024 | $2.42 Billion | $18.12 Billion | $1.30 Billion | 0.13x | 1.86x |
| 2025 | $2.24 Billion | $18.02 Billion | $237.00 Million | 0.12x | 9.46x |
Competitor Companies of EKTA-B by Market Capitalization
Companies near Elekta AB (publ) in the global market cap rankings as of November 1, 2026. Also see Elekta AB (publ) total assets for a full breakdown of the balance sheet.
Key companies related to Elekta AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Elekta AB (publ) (2015–2026)
Market capitalization of Elekta AB (publ) from 2015 to today. Between 2015 and today, Elekta AB (publ)'s market cap moved from $2.38 Billion to $ 2.36 Billion, with a yearly change of 0.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr2.36 Billion | +5.20% |
| 2025 | Skr2.24 Billion | -7.20% |
| 2024 | Skr2.42 Billion | -23.11% |
| 2023 | Skr3.14 Billion | +35.34% |
| 2022 | Skr2.32 Billion | -43.34% |
| 2021 | Skr4.10 Billion | +5.54% |
| 2020 | Skr3.88 Billion | -8.95% |
| 2019 | Skr4.26 Billion | +18.71% |
| 2018 | Skr3.59 Billion | +58.03% |
| 2017 | Skr2.27 Billion | -14.93% |
| 2016 | Skr2.67 Billion | +12.17% |
| 2015 | Skr2.38 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Elekta AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.36 Billion USD |
| MoneyControl | $2.36 Billion USD |
| MarketWatch | $2.36 Billion USD |
| marketcap.company | $2.36 Billion USD |
| Reuters | $2.36 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more